Aptuit To Acquire EaglePicher Pharmaceutical Services
Aptuit, Inc. (Greenwich, CT) has agreed to acquire the assets and operations of EaglePicher Pharmaceutical Services (EPPS, Lenexa, KS) as part of Aptuit?s strategies to build capabilities in active pharmaceutical ingredient (API) development and drug substance manufacturing.
Greenwich, CT (Sept. 26)––Aptuit, Inc. (Greenwich, CT, www.aptuit.com) agreed to acquire the assets and operations of EaglePicher Pharmaceutical Services (EPPS, Lenexa, KS, www.eaglepicher.com) as part of Aptuit’s strategy to build capabilities in active pharmaceutical ingredient (API) development and drug substance manufacturing.
Aptuit will acquire EaglePicher’s facilities in Lenexa, Kansas and Harrisonville, Missouri and plans further investments. “We intend to make significant investments in our new API operation over the next 18 months to upgrade the EPPS Harrisonville facility, extend its range of capabilities, and improve its regulatory profile,” said Michael A. Griffith, CEO of Aptuit, in a company release. “Additionally, we will be building a first-class lab-based process-development and kilo-lab capability.”
The acquisition extends Aptuit’s capabilities to include API supply from post discovery to market. Following the acquisition, Aptuit will have 12 facilities globally, including a clinical trial distribution network of 27 supply depots. The acquisition is expected to close within 90 days.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
